Qianjiang Yongan Pharmaceutical Co Ltd (002365) — Financial Flexibility Index
Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Financial Flexibility Index of 0.28x as of September 2025. Free cash flow of CN¥70.03 Million (operating CF CN¥58.18 Million minus capex CN¥11.85 Million) represents 0% of total liabilities (CN¥247.20 Million). Check strategic asset allocation of Qianjiang Yongan Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Qianjiang Yongan Pharmaceutical Co Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Qianjiang Yongan Pharmaceutical Co Ltd across 19 annual periods. See working capital to net assets of Qianjiang Yongan Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Qianjiang Yongan Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002365 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.84x | CN¥223.76 Million | CN¥105.71 Million | CN¥266.55 Million | ▼ -31.3% |
| 2023 | 1.22x | CN¥365.00 Million | CN¥244.26 Million | CN¥298.85 Million | ▼ -26.9% |
| 2022 | 1.67x | CN¥536.35 Million | CN¥387.28 Million | CN¥321.17 Million | ▲ +233.2% |
| 2021 | 0.50x | CN¥164.86 Million | CN¥101.81 Million | CN¥328.95 Million | ▼ -43.6% |
| 2020 | 0.89x | CN¥311.07 Million | CN¥206.66 Million | CN¥349.92 Million | ▼ -40.3% |
| 2019 | 1.49x | CN¥373.94 Million | CN¥239.55 Million | CN¥251.14 Million | ▼ -17.5% |
| 2018 | 1.81x | CN¥583.52 Million | CN¥314.02 Million | CN¥323.11 Million | ▼ -12.7% |
| 2017 | 2.07x | CN¥486.79 Million | CN¥197.32 Million | CN¥235.23 Million | ▲ +59.7% |
| 2016 | 1.30x | CN¥124.66 Million | CN¥84.53 Million | CN¥96.22 Million | ▲ +3.3% |
| 2015 | 1.25x | CN¥104.73 Million | CN¥70.61 Million | CN¥83.50 Million | ▲ +41.9% |
| 2014 | 0.88x | CN¥69.95 Million | CN¥19.26 Million | CN¥79.14 Million | ▼ -33.8% |
| 2013 | 1.34x | CN¥163.57 Million | CN¥63.65 Million | CN¥122.50 Million | ▼ -18.5% |
| 2012 | 1.64x | CN¥190.93 Million | CN¥70.75 Million | CN¥116.59 Million | ▼ -49.7% |
| 2011 | 3.26x | CN¥339.26 Million | CN¥91.23 Million | CN¥104.13 Million | ▲ +67.0% |
| 2010 | 1.95x | CN¥148.58 Million | CN¥44.06 Million | CN¥76.14 Million | ▲ +65.4% |
| 2009 | 1.18x | CN¥82.41 Million | CN¥36.43 Million | CN¥69.83 Million | ▼ -38.6% |
| 2008 | 1.92x | CN¥230.66 Million | CN¥158.47 Million | CN¥120.04 Million | ▼ -0.8% |
| 2007 | 1.94x | CN¥121.85 Million | CN¥61.08 Million | CN¥62.89 Million | ▲ +83.6% |
| 2006 | 1.06x | CN¥48.79 Million | CN¥31.11 Million | CN¥46.24 Million | — |